Petr Valha

Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial

Lukáš Rob, David Cibula, Paweł Knapp et al. · Journal for ImmunoTherapy of Cancer · 2022 · 50 citations · Full text

Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial

David Cibula, Lukáš Rob, Peter Mallmann et al. · Gynecologic Oncology · 2021 · 44 citations · Full text

Malignant changes in adenomyosis in patients with endometrioid adenocarcinoma.

E Kučera, Václav Hejda, Róbert Dankovčík et al. · PubMed · 2011 · 33 citations

Refractometric study of systems water-poly(ethylene glycol) for preparation and characterization of Au nanoparticles dispersion

Zdeňka Kolská, Petr Valha, Petr Slepička et al. · Arabian Journal of Chemistry · 2016 · 19 citations · Full text